Uncategorized

By David Tuller, DrPH It’s a frightening time for everyone. As we know, people with underlying medical conditions are at greater risk from coronavirus. At the same time, many of these individuals long ago adopted some of the strategies everyone is now being asked to adopt. Certainly people with ME–or with what is referred to […]

by Helen Stillwell Helen is a research associate in David Hafler€™s immunobiology lab at Yale University; previously, she worked on poxviruses at Tonix Pharmaceuticals, and she plans to apply to PhD programs in virology this year. RT-PCR Diagnostics As cases of COVID-19 continue to rise, diagnostic testing has been a principal topic of discussion. Typically,

Chloroquine (and a derivative, hydroxychloroquine) has been used for years in the treatment of malaria. The drug is also known to block the entry of many viruses into cells. A small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients.

By David Tuller, DrPh Like many or most, I don€™t know what I€™m supposed to be doing right now. I am €œsheltering at home€ in San Francisco, following the news, making way too many cups of coffee, chatting much more on the phone than usual, checking in with my 90-year-old mom in Manhattan, watching movies

by Helen Stillwell Helen is a research associate in David Hafler€™s immunobiology lab at Yale University; previously, she worked on poxviruses at Tonix Pharmaceuticals, and she plans to apply to PhD programs in virology this year. Is there a vaccine for SARS-CoV-2? The internet is awash with articles and posts seeking to shed light on

By David Tuller, DrPH And here’s yet another study from Professor Trudie Chalder and colleagues at King’s College London, this time tackling fatigue in people with HIV, an often debilitating problem. The study, “A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors”, was published online last month by